ESC Professional Premium Access

Antithrombotic therapy in TAVI patients with indication for oral anticoagulation.

Congress Presentation

About the speaker

Professor Marco Valgimigli

Cardiocentro Ticino Foundation, Lugano (Switzerland)
29 presentations
5 followers

4 more presentations in this session

Embolic stroke. Ischaemic and bleeding risk in patients undergoing TAVI.

Speaker: Professor D. Capodanno (Catania, IT)

Thumbnail

Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.

Speaker: Professor G. Dangas (New York, US)

Thumbnail

Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.

Speaker: Doctor M. Joner (Munich, DE)

Thumbnail

What you need to know about antithrombotic therapy in patients after TAVI – discussion.

Thumbnail

Access the full session

What you need to know about antithrombotic therapy in patients after TAVI

Speakers: Professor M. Valgimigli, Professor D. Capodanno, Professor G. Dangas, Doctor M. Joner
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb